These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 872096)

  • 1. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 3. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity.
    Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L
    Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Ferrans VJ
    Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anthracycline antibiotic-induced cardiomyopathy in rabbits.
    Jaenke RS
    Lab Invest; 1974 Mar; 30(3):292-304. PubMed ID: 4817824
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
    Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
    Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of myocardial mitochondria in the adriamycin-induced cardiomyopathy of rabbits.
    Bier CC; Jaenke RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1091-4. PubMed ID: 1003544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature.
    Lieverse RJ; Ossenkoppele GJ
    Neth J Med; 1991 Feb; 38(1-2):33-4. PubMed ID: 2030807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of anthracycline antineoplastic drugs--Clinicopathological and experimental studies.
    Suzuki T; Kanda H; Kawai Y; Tominaga K; Murata K
    Jpn Circ J; 1979 Nov; 43(11):1000-8. PubMed ID: 522231
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin and daunorubicin disposition in the rabbit.
    Bachur NR; Hildebrand RC; Jaenke RS
    J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for development of daunorubicin cardiotoxicity.
    Von Hoff DD; Layard M
    Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N; Singal PK
    Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 20. Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
    Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.